Biomarkers of neurodegeneration in isolated and antidepressant-related rapid eye movement sleep behavior disorder
- PMID: 38409939
- PMCID: PMC11235591
- DOI: 10.1111/ene.16260
Biomarkers of neurodegeneration in isolated and antidepressant-related rapid eye movement sleep behavior disorder
Abstract
Background and purpose: This study compared the features of isolated rapid eye movement (REM) sleep behavior disorder (iRBD) and antidepressant-related REM sleep behaviour disorder (RBD) with the aim of highlighting markers that might distinguish the two entities.
Methods: The observational cohort study included RBD patients with and without antidepressant use (antiD+ and antiD- patients, respectively), without cognitive impairment and parkinsonism. Clinical features of RBD, subtle motor and non-motor symptoms of parkinsonism, sleep architecture, REM atonia index, dopamine transporter-single photon emission computed tomography (DAT-SPECT) and skin biopsies for the intraneuronal alpha-synuclein (α-syn), were evaluated in the baseline work-up.
Results: Thirty-nine patients, 10 antiD+ and 29 antiD-, were included. AntiD+ patients (more frequently female) reported more psychiatric symptoms, less violent dream enactment, and less frequent hyposmia. Dermal α-syn was detected in 93.1% of antiD- versus 30% of antiD+ patients (p = 0.00024). No differences appeared in other motor and non-motor symptoms, Movement Disorder Society-Unified Parkinson's Disease Rating Scale part III score, DAT-SPECT, or polysomnographic features.
Conclusions: Patients with antidepressant-related RBD have clinical and neuropathological features suggesting a lower risk of evolution than those with iRBD.
Keywords: alpha‐synuclein; antidepressant‐related REM sleep behavior disorder; skin biopsy.
© 2024 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.
Conflict of interest statement
The authors declare that there are no conflicts of interest relevant to this work.
References
-
- Lam SP, Zhang J, Li SX, Wing YK. RBD, antidepressant medications, and psychiatric disorders. Rapid‐Eye‐Move Sleep Behav Disord. 2018;18:123‐134. doi:10.1007/978-3-319-90152-7_10 - DOI
-
- American Academy of Sleep Medicine . International Classification of Sleep Disorders. American Academy of Sleep Medicine; 2014. doi:10.1007/978-1-4939-6578-6_27 - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous